alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

113TH CONGRESS 

2D SESSION H. R. 5678 

To direct the Secretary of Education to conduct a study to determine the 

relationship between school start times and adolescent health, well-being, 

and performance. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 19, 2014 

Ms. LOFGREN (for herself, Mr. HONDA, and Mr. MORAN) introduced the following bill; which was referred to the Committee on Education and the 

Workforce 

A BILL 

To direct the Secretary of Education to conduct a study 

to determine the relationship between school start times 

and adolescent health, well-being, and performance. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘ZZZ’s to A’s Act’’. 

5 SEC. 2. FINDINGS. 

6 Congress finds the followings: 

7 (1) The Secretary of Education has not for8 mally issued policy guidance on school start times. 


emcdonald on DSK67QTVN1PROD with BILLS
2 

•HR 5678 IH

1 (2) Numerous local educational agencies have 

2 recently changed or are considering changing school 

3 start times in an effort to improve adolescent health, 

4 well-being, and performance. 

5 SEC. 3. STUDY AND REPORT. 

6 Not later than 18 months after the date of enactment 

7 of this Act, the Secretary of Education shall— 

8 (1) conduct a study, directly or through award9 ing a grant or contract, to examine the relationship 

10 between school start times and adolescent health, 

11 well-being, and performance that— 

12 (A) provides a comprehensive review of the 

13 scientific evidence relating to school start times 

14 and adolescent health, well-being, and perform15 ance; 

16 (B) compares adolescent health, well-being, 

17 and performance among local educational agen18 cies with different school start times; and 

19 (C) evaluates factors that contribute to or 

20 affect school start times; and 

21 (2) submit to Congress a report that de22 scribes— 

23 (A) the findings of the study; and 

24 (B) any recommendations of the Secretary 

25 based on such findings. 


emcdonald on DSK67QTVN1PROD with BILLS
3 

•HR 5678 IH

1 SEC. 4. DEFINITIONS. 

2 In this Act: 

3 (1) LOCAL EDUCATIONAL AGENCY.—The term 

4 ‘‘local educational agency’’ has the meaning given 

5 the term in section 9101 of the Elementary and Sec6 ondary Education Act of 1965 (20 U.S.C. 7801). 

7 (2) PERFORMANCE.—The term ‘‘performance’’ 

8 means a measurement of how well an individual 

9 achieves a desired task, and which may include aca10 demic performance and cognitive performance. 

11 (3) SECRETARY.—The term ‘‘Secretary’’ means 

12 the Secretary of Education. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS
<TABLE> <S> <C>


<ARTICLE> 5

<S>                                           <C>
<PERIOD-TYPE>                                3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-2000
<CASH>                                           5,300
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 8,100
<PP&E>                                           6,460
<DEPRECIATION>                                   1,813
<TOTAL-ASSETS>                                 128,808
<CURRENT-LIABILITIES>                          163,900
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        121
<COMMON>                                           597
<OTHER-SE>                                   (505,276)
<TOTAL-LIABILITY-AND-EQUITY>                   128,808
<SALES>                                          6,350
<TOTAL-REVENUES>                                 6,350
<CGS>                                            9,610
<TOTAL-COSTS>                                  119,909
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,000
<INCOME-PRETAX>                              (128,559)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (128,559)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (128,559)
<EPS-BASIC>                                      (.03)
<EPS-DILUTED>                                    (.03)






</TABLE>
Exhibit
10.1


 





 


June 17,
2009


 


Michael
N. Chang, Ph.D.


Optimer
Pharmaceuticals, Inc.


10110
Sorrento Valley Road, Suite C


San
Diego, CA 92121


 


Re:          Amendment to Employment Agreement


 


Dear
Michael:


 


This
Amendment (the “Amendment”)
to your Employment Agreement with Optimer Pharmaceuticals, Inc.
(the “Company”) dated June 17, 2005, as
amended (the “Agreement”),
amends the terms and conditions of the Agreement to the extent provided
herein. The Agreement is currently scheduled to expire according to its terms on
June 17, 2009 and you and the Company have expressed a desire to continue
the Agreement for an additional 4 year term.


 


In
light of the foregoing, Section 2.3 of the Agreement shall be amended and
restated in its entirety to read as follows:


 


“2.3.
Term of Employment. The Executive’s employment
under this Agreement (the “Employment Term”) shall commence as of the effective date hereof and
shall terminate on the earlier of (a) the eighth year anniversary of the
date hereof, or (b) the termination of the Executive’s employment pursuant
to this Agreement. Executive may terminate his employment with the Company at
any time and for any reason upon thirty (30) days’ prior written notice to the
Company.”


 


Except
as specifically amended by this Amendment, the terms and conditions of the
Agreement shall remain in full force and effect. This Amendment may be executed
in two or more counterparts, each of which shall be deemed an original and all
of which together shall constitute one and the same instrument. Please sign
this Amendment and return it to the Company at your earliest convenience.


 


Sincerely,


 


	
  OPTIMER PHARMACEUTICALS, INC.

  
	
   

  
	
  By:  

  	
  /s/
  Alain Schreiber, M.D.

  	
   

  	
   

  
	
   

  	
  Alain
  Schreiber, M.D.

  	
   

  	
   

  
	
   

  	
  Director

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Accepted
  and Agreed:

  
	
   

  	
   

  
	
   

  	
  /s/ Michael N. Chang, Ph.D.

  
	
   

  	
  Michael N. Chang, Ph.D.

  



 


10110 SORRENTO VALLEY ROAD, SUITE C SAN DIEGO, CALIFORNIA 92121
TEL:858-909-0736 FAX:858-909-0737
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>

This schedule contains summary financial information extracted from Financial
Statements for the six (6) months ended June 30, 2000, and is qualified in
its entirety by reference to such form 10-QSB for quarterly period ended June 30
2000.

</LEGEND>
<MULTIPLIER> 1

<S>                                          <C>


<PERIOD-TYPE>                                       6-MOS
<FISCAL-YEAR-END>                             Dec-31-2000
<PERIOD-START>                                Jul-01-2000
<PERIOD-END>                                  Sep-30-2000
<CASH>                                             45,921
<SECURITIES>                                            0
<RECEIVABLES>                                           0
<ALLOWANCES>                                            0
<INVENTORY>                                             0
<CURRENT-ASSETS>                                  192,322
<PP&E>                                            232,817
<DEPRECIATION>                                     45,710
<TOTAL-ASSETS>                                  2,622,672
<CURRENT-LIABILITIES>                              36,506
<BONDS>                                                 0
<COMMON>                                        5,845,755
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<OTHER-SE>                                              0
<TOTAL-LIABILITY-AND-EQUITY>                    2,622,672
<SALES>                                                 0
<TOTAL-REVENUES>                                    4,216
<CGS>                                                   0
<TOTAL-COSTS>                                   1,477,709
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                  4,084
<INCOME-PRETAX>                                (1,477,577)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                            (1,477,577)
<DISCONTINUED>                                   (405,796)
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                   (1,883,373)
<EPS-BASIC>                                          (.16)
<EPS-DILUTED>                                        (.16)





</TABLE>
I 

113TH CONGRESS 

2D SESSION H. R. 5596 

To provide borrowers of Federal Family Education Loans with the repayment 

terms available to borrowers of Federal Direct Loans, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 18, 2014 

Mr. GARCIA (for himself, Mr. HASTINGS of Florida, Mr. MURPHY of Florida, 

and Mr. PAYNE) introduced the following bill; which was referred to the 

Committee on Education and the Workforce 

A BILL 

To provide borrowers of Federal Family Education Loans 

with the repayment terms available to borrowers of Federal Direct Loans, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Fairness in Student 

5 Loan Repayment Act’’. 


tkelley on DSK3SPTVN1PROD with BILLS
2 

•HR 5596 IH

1 SEC. 2. REPAYMENT TERMS FOR FEDERAL FAMILY EDU2 CATION LOANS. 

3 (a) IN GENERAL.—Section 455 of the Higher Edu4 cation Act of 1965 (20 U.S.C. 1087e) is amended by add5 ing at the end the following new subsection: 

6 ‘‘(r) REPAYMENT TERMS FOR FEDERAL FAMILY

7 EDUCATION LOANS.— 

8 ‘‘(1) APPLICABILITY OF PROGRAMS AVAILABLE

9 UNDER THIS SECTION.—The Secretary shall apply 

10 subsections (d), (e), (f), (l), (m), and (o) to all loans 

11 made under part B as if such loans were made 

12 under this part. 

13 ‘‘(2) PAYMENT OF BALANCE AND INTEREST.— 

14 In carrying out paragraph (1), the Secretary shall 

15 pay to the holder of a loan made under part B the 

16 amount of principal, interest, or special allowance 

17 payments necessary to apply subsections (d), (e), (f), 

18 (l), (m), and (o) to such loan, as appropriate.’’. 

19 (b) CONSOLIDATION LOANS.—Section 

20 428C(a)(3)(B)(i) of the Higher Education Act of 1965 

21 (20 U.S.C. 1087–3(a)(3)(B)(i)) is amended— 

22 (1) in subclause (III), by striking the semicolon 

23 and inserting ‘‘; and’’; 

24 (2) in subclause (IV), by striking ‘‘; and’’ and 

25 inserting a period; and 


tkelley on DSK3SPTVN1PROD with BILLS
3 

•HR 5596 IH

1 (3) by striking subclause (V). 

Æ 


tkelley on DSK3SPTVN1PROD with BILLS
UNPUBLISHED

UNITED STATES COURT OF APPEALS 

FOR THE FOURTH CIRCUIT 

No. 08-7084

UNITED STATES OF AMERICA, 

 Plaintiff - Appellee, 

 v. 

CRYSTAL RAMONA HICKSON, a/k/a Auntie, a/k/a Crystal A. 

Hickson, 

 Defendant - Appellant. 

Appeal from the United States District Court for the Eastern 

District of Virginia, at Norfolk. Walter D. Kelley, Jr., 

District Judge. (2:07-cr-00030-WDK-FBS-3) 

Submitted: December 11, 2008 Decided: December 17, 2008 

Before NIEMEYER, DUNCAN, and AGEE, Circuit Judges. 

Affirmed by unpublished per curiam opinion. 

Crystal Ramona Hickson, Appellant Pro Se. Darryl James Mitchell, 

Assistant United States Attorney, Norfolk, Virginia, for 

Appellee.

Unpublished opinions are not binding precedent in this circuit. 
2 

PER CURIAM: 

Crystal Ramona Hickson appeals the district court’s 

order denying her 18 U.S.C. § 3582 (2006) motion for reduction 

of sentence. We have reviewed the record and find no reversible 

error. Accordingly, we affirm for the reasons stated by the 

district court. United States v. Hickson, No. 

2:07-cr-00030-WDK-FBS-3 (E.D. Va. May 16, 2008). We dispense 

with oral argument because the facts and legal contentions are 

adequately presented in the materials before the court and 

argument would not aid the decisional process. 

AFFIRMED
Exhibit 31.1**CERTIFICATION**
I, Robert C. Salipante, certify that: 

1.	I have reviewed this quarterly report on Form 10-Q of Sun Life Assurance Company of Canada (U.S.);

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

(b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

(c) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 

Date: November 10, 2004

 
 */s/ Robert C. Salipante                       
Robert C. Salipante  
President*
November 13, 2014

JUDGMENT

The Fourteenth Court of Appeals

BACM 2006-4 PARK ROW, LLC, Appellant

NO. 14-14-00651-CV V.

EZRA BEYMAN, Appellee

________________________________

Today the Court heard appellant’s motion to dismiss the appeal from the 

judgment signed by the court below on May 14, 2014. Having considered the 

motion and found it meritorious, we order the appeal DISMISSED.

We further order that all costs incurred by reason of this appeal be paid by 

appellant, BACM 2006-4 Park Row, LLC.

We further order that mandate be issued immediately.

We further order this decision certified below for observance.
UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF COLUMBIA 

FILED 

~£P L 0 2010 

David Ezell Simpson, ) 

) 

) 

) 

) 

) 

) 

) 

) 

Clerk, U.S. District & Bankruptcy 

Courts for the District of Columbia 

Petitioner, 

v. Civil Action No. 10 1589 

Judith Simon Garrett et aI., 

Respondents. 

MEMORANDUM OPINION 

This matter, brought pro se, is before the Court on its initial review of the petition for a 

writ of mandamus and application to proceed in forma pauperis. The Court will grant the 

application to proceed in forma pauperis and dismiss the case for lack of jurisdiction. 

Petitioner is a federal prisoner confined at a state or local facility in Raleigh, North 

Carolina, awaiting trial on state charges. He seeks issuance of a writ of mandamus to compel his 

"immediate return to federal custody." Pet. at 14. Because this claim is properly pursued by 

applying for a writ of habeas corpus, mandamus relief is not available. See Muhammad v. Close, 

540 U.S. 749, 750 (2004) ("Challenges to the validity of any confinement or to particulars 

affecting its duration are the province of habeas corpus[.]") (citation omitted); Chatman-Bey v. 

Thornburgh, 864 F.2d 804, 806 (D.C. Cir. 1988) (where "habeas is an available and potentially 

efficacious remedy, it is clear beyond reasonable dispute that mandamus will not appropriately 

lie"). Moreover, only the Court having jurisdiction over petitioner's immediate custodian, 

namely, the United States District Court for the Eastern District of North Carolina, may entertain 

the habeas claim. See Rooney v. Sec y of Army, 405 F.3d 1029, 1032 (D.C. Cir. 2005) (habeas 

3 
"jurisdiction is proper only in the district in which the immediate, not the ultimate, custodian is 

located.") (internal citations and quotation marks omitted); Simpson v. Dep 't of Justice, Civ. 

Action No. 10-0920 (Transfer Order, June 4, 2010) 

civil action). A separate Order of dismissava"'~J.,," 

Date: Septembel!!-, 2010 

d States District Judge 

2
[Federal Register Volume 75, Number 109 (Tuesday, June 8, 2010)]
[Notices]
[Page 32489]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-13708]



-----------------------------------------------------------------------



DEPARTMENT OF HEALTH AND HUMAN SERVICES



National Institutes of Health




National Cancer Institute; Notice of Closed Meeting



    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is hereby given of the following 

meeting.

    The meeting will be closed to the public in accordance with the 

provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 

U.S.C., as amended. The grant applications and the discussions could 

disclose confidential trade secrets or commercial property such as 

patentable material, and personal information concerning individuals 

associated with the grant applications, the disclosure of which would 

constitute a clearly unwarranted invasion of personal privacy.



    Name of Committee: National Cancer Institute Initial Review 

Group; Subcommittee H--Clinical Groups.

    Date: July 19-20, 2010.

    Time: 8 a.m. to 8 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 

20814.

    Contact Person: Timothy C. Meeker, MD, PhD, Scientific Review 

Officer, Resources and Training Review Branch, Division of 

Extramural Activities, National Cancer Institute, 6116 Executive 

Boulevard, Room 8103, Bethesda, MD 20892, (301) 594-1279, 

<a href="/cdn-cgi/l/email-protection#bbd6deded0dec9cffbd6dad2d795d5d2d395dcd4cd"><span class="__cf_email__" data-cfemail="254840404e4057516548444c490b4b4c4d0b424a53">[email protected]</span></a>.



(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 

Cancer Construction; 93.393, Cancer Cause and Prevention Research; 

93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 

Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 

Control, National Institutes of Health, HHS)



    Dated: June 4, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-13708 Filed 6-7-10; 8:45 am]

BILLING CODE 4140-01-P




</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
CitiMortgage, Inc.
4000 Regent Blvd., 3rd Floor
Irving, TX 75063
Attention: Master Servicing Division, John Guyon ( HALO 2007-AR1)


      Re: Annual Compliance Statement for HALO 2007-AR1

      In connection with the loans serviced by SunTrust Mortgage, Inc.
      (the "Company") pursuant to the Company's Servicing
      Agreement(s)/Purchase and Sale Agreement(s) with HSBC Bank USA,
      National Association and any applicable Reconstitution
      Agreement(s) (together, the "Transaction Agreements"), I, the
      undersigned officer, hereby certify the following as of December
      31, 2007:

      (i)     The Company conducted a review of its activities during
              the immediately preceding calendar year (or applicable
              portion thereof) and of its performance under the
              Transaction Agreements during such period has been made
              under my supervision; and

      (ii)    To the best of my knowledge, based on such review, the
              Company has fulfilled all of its obligations under the
              Transaction Agreements in all material respects
              throughout such calendar year (or applicable portion
              thereof), except as follows:

           -  SunTrust Mortgage did not maintain the required fidelity
              bond coverage amount in accordance with Section
              229.1122(d)(i)(iv) at all times during 2007. The Company
              maintained fidelity bond coverage in the amount of $150MM
              throughout calendar year 2007, which was determined to be
              insufficient according to applicable FNMA transaction
              agreement terms. This deficiency was an issue for limited
              portions of the year and resulted from an increase in the
              volume of the servicing portfolio. SunTrust Mortgage has
              requested a waiver from FNMA stating this coverage amount
              is adequate without regard for the size of the
              residential servicing portfolio, subject to an annual
              FNMA review. FNMA has verbally agreed to this request,
              and SunTrust Mortgage is working to formalize this
              agreement.



      IN WITNESS WHEREOF, I do hereby certify the foregoing as of the
      date hereof.




      /s/John R. Purcell, Jr.
      ------------------------------------
      John R. Purcell, Jr.
      Senior Vice President- Manager, Servicing Division

      Date:  March 12, 2008